[ad_1]
Prof Murray believes that “compassionate use” guidelines are open to exploitation by professors who want to further their own research.
Indeed, three months after Miss Davison’s death, Prof Birchall wrote an opinion piece in The Lancet about the advantages of compassionate cases “in preclinical data for clinical trial applications”.
He said that when making applications for trials, clinical data obtained from humans operated on under the “compassionate use” policy can be used “in place of or in addition to” animal studies.
“Importantly, these first-in-man compassionate studies are powerful ways to inform robustly designed formal trials which are often complex and require frequent amendments,” he added.
Prof Murray and Dr Levy have spent the past 12 months writing to funding councils, regulatory authorities, UCL and MPs in an attempt to raise concerns about patient safety.
Earlier this year, the vice-Chancellor of Liverpool University was sent two letters from a law firm acting Videregen, the commercial partner with UCL for one of the trials.
Lawyers accused Prof Murray and Dr Levy of damaging Videregen’s reputation and said threatened to sue to academics for damages.
[ad_2]
Source link
